A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg

Clinical trial NCT04332874 · RECRUITING

Trial details

NCT number: NCT04332874
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Sarcoma Myxofibrosarcoma Undifferentiated Pleomorphic Sarcoma Alveolar Soft Part Sarcoma

Start date: 2020-04-01
Primary completion: 2027-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.